Abstract
The present investigation concerns the experimental design in preparing a solid dispersion of ionized carvedilol with hydroxypropyl-β-cyclodextrin (HPβCD), tartaric acid (TA) by adopting ‘kneading technique’. Simplex lattice design has been chosen to develop model equations that correlate the process variables such as HPβCD (mg), TA (mg), and kneading time (min) with the response variables, such as solubility (mg/mL) and drug release (%) from the solid dispersion. Software-generated ANOVA results confirmed the sufficiency of model equations. Results predicted by model equations are in good agreement with that of experimental results. Optimized formulation with variables ‘CV: HPβCD: TA-kneading time’ (200mg: 689.6mg: 227.6mg–45 min) showed complete drug release (∼99%) within 15 min and enhanced solubility of 1.89mg/mL. The instrumental analysis (DSC, XRD& FTIR) of the optimized solid dispersion suggests a transformation of crystallinity of drug to amorphous form, due to its complexation with HPβCD. Hence, this combination of drug and carriers suggests an improvement of carvedilol bioavailability.
Similar content being viewed by others
References
R.C. Nagarwal, A. Srinatha and J. K. Pandit, AAPS PharmSciTech., 10, 977 (2009).
D.T. Friesen, M. Crew, W. J. Curatolo, J.A. S. Nightingale, R. Shanker and D. T. Smithey, Mol. Pharm., 5, 1003 (2008).
V. J. Stella and K.W.N. Addae, Adv. Drug Deliv. Rev., 59, 677 (2007).
A. T. M. Serajuddin, Adv. Drug Deliv. Rev., 59, 603 (2007).
H. G. Brittain, J. Pharm. Sci., 91, 1573 (2002).
M. Li, A. Davies, N. Malek, N. Qiao, W. Schlindwein and G. Trappitt, Int. J. Pharm., 419, 1 (2011).
T. Loftsson, C. Amiel, P. Jansook, K.L. Larsen, M. Messner, M.D. Moya-Ortega, T.T. Nielsen, H. H. Sigurdsson and V. Wintgens, J. Inclus. Phenom. Macro. Chem., 69, 377 (2011).
M.A. Rahman, R. Harwansh, A. Hussain, S. Hussain and M.A. Mirza, Curr. Drug Deliv., 8, 330 (2011).
C. M. Keck, S. Gohla and R. H. Muller, Eur. J. Pharm. Biopharm., 78, 1 (2011).
J.K. Lee, K.B. Kim and M.H. Lee, Intermetallics, 18, 2019 (2010).
A. T. M. Serajuddin, J. Pharm. Sci., 10, 1058 (1999).
T. Loftsson, M. Masson, N. Schipper and H. H. Sigurdsson, Pharmazie, 59, 25 (2004).
M. P. Buera, P. A. P. Cevallos and B. E. Elizalde, J. Food Eng., 99, 70 (2010).
D. Duchene and D. Wouessidjewe, Drug Dev. Ind. Pharm., 16, 2487 (1990).
W. Misiuk and M. Zalewska, Carbohydr. Polym., 77, 482 (2009).
G. A. Lewis, D. Mathieu and R. P.T. Luu, Pharmaceutical experimental design, CRC Press, New York.
James Goodnight., JMP 10 Design of Experiments Guide, SAS Publishing, Cary, 177 (2012).
V. Pokharkar, S. Dhar, A. Khanna, L. Mandpe and V. Venkatpurwar, Acta Pharm., 59, 121 (2009).
W.H. Karasov and J.M. Diamond, J. Comp. Physiol. [B], 152, 105 (1983).
R. Bouer, L. Barthe, G. Houin, C. Philibert, C. Tournaire and J. Woodley, Fundam Clin Pharmacol., 13, 494 (1999).
P. Mura, G. Bramanti, M.T. Faucci and A. Manderioli, J. Incl. Phenom. Macroc. Chem., 39, 131 (2001).
J.J.T. Labanderia, M.T. E. Diaz, M. Kata and J. L.V. Jato, Eur. J. Pharm. Sci., 1, 291 (1994).
M.J. Ginski, J. E. Polli and R. Taneja, Int. J. Pharm., 177, 117 (1999).
A. Paradkar, A. A. Ambike, B. K. Jadhav and K.R. Mahadik, Int. J. Pharm., 271, 281 (2004).
J. Wang, Y. Cao, B. Sun and C. Wang, Food Chem., 124, 1069 (2011).
R.N. Shamma and M. Basha, Powder Technol., 237, 406 (2013).
E. Pincu and V. Meltzer, Cent. Eur. J. Chem., 10, 1584 (2012).
A. Paradkar, A. A. Ambike, K.R. Mahadik, L. P. Mandpe, M. N. Padamwar and V. B. Pokharkar, Powder Technol., 167, 20 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuvaraja, K., Das, S.K. & Khanam, J. Process optimization and characterization of carvedilol solid dispersion with hydroxypropyl-β-cyclodextrin and tartaric acid. Korean J. Chem. Eng. 32, 132–140 (2015). https://doi.org/10.1007/s11814-014-0192-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11814-014-0192-2